Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Aurobindo Pharma's Eugia Pharma approved to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel, ...

Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats ...

Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...

Belgium's pharmaceutical sector is facing mounting domestic pressure from analysts concerned about the undermining of ...

Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Mumbai: Sun Pharma and Israel-based Moebius Medical Limited have announced the publication of two articles in Osteoarthritis ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...